The need for a preventive agent against dementia led us to screen natural plant resources. Among the herbs and spices tested, turmeric, from rhizomes of Curcuma longa, showed high potency against β-secretase. The active principles were determined as α-turmerone, β-turmerone and ar-turmerone, with IC 50 values of 39, 62 and 92 µM respectively. In this study, the efficiency of collecting the essential oil using steam distillation of the volatile substance was disclosed. The active principles were explored, and four sesquiterpenoids and five monoterpenoids were revealed as active principles against β-secretase. On the other hand, α-turmerone, β-turmerone and ar-turmerone were also investigated in a pharmacokinetic absorption experiment. After oral administration, these compounds were detected in an intact form in the brain and serum. These results suggest that consumption of turmeric constituents may prevent dementia.
Our research program to investigate preventive remedies for dementia, especially Alzheimer's disease (AD), has successfully revealed that β-secretase screening and pharmacokinetic experiments using plant resources are a promising strategy [1, 2] . Results have shown that some spices and herbs used in Asian countries are effective against β-secretase, and sesamin and sesamolin reached the brain when administered orally to mice.
In our previous report, hexane and ethyl acetate extracts of Curcuma longa rhizomes showed high potency against β-secretase [1] . The active principles were determined as α-turmerone, βturmerone and ar-turmerone ( Fig. 1) , with IC 50 values of 39, 62 and 92 µM, respectively. These results prompted us to investigate an efficient method of obtaining extracts effective for AD from plant material. We focused on the steam distillation method as a suitable extraction procedure for obtaining the essential oils and volatile compounds [3] . We utilized this method for C. longa rhizomes and showed that the extraction of turmerones is more efficient compared with the solvent extraction used previously [1] . Moreover, vacuum distillation could separate the contents of essential oil extracts obtained by steam distillation efficiently. In this report, the results of the extraction method and the determination of extract contents showed the efficiency of the extraction method. Moreover, we successfully determined the active principles contained in the essential oil extract and the structures and potencies were revealed.
There are only a few studies on the pharmacokinetic properties of turmerones, especially α-and β-turmerone [4] due to the difficulties of isolation and a shortage of the compounds available from natural sources. In fact, the isolation yield was very low in our previous study, possibly due to volatility [1] . Thus, the introduction of an original and efficient isolation method led to the isolation of α-and β-isomers and ar-type turmerones in a pure form that enabled testing to show whether the compounds would pass through the blood-brain barrier to reach the brain in an intact form. If the compounds are able to reach the brain, there is a high potential for preventing AD. (1), β-turmerone (2), ar-turmerone (3), l-zingiberene (4), β-sesquiphellandrene (5), ar-curcumene (6) and β-bisabolene (7) .
In this report, results on the extraction procedure and the components in essential oil extracts are discussed. Moreover, the results of pharmacokinetic studies on turmerones are presented to show the efficacy of turmerones for the prevention of AD.
GC analyses of the essential oil extract and fractions obtained from the vacuum distillation of turmeric were performed to reveal the contents of volatile compounds [5] . The results are shown in Table  1 . Fractions were obtained in a series of increasing temperatures as described in the Experimental section. Among the fractions obtained, Fr. 4 showed the highest yield at 46.6%, with a main content of turmerones at up to 79.0%. Relatively higher yields were observed in Fr. 3 and 5 at 21.0% and 15.5%, respectively. Their content was also revealed as turmerones. From these results, the higher temperature extracts provided higher turmerone contents showing that vacuum distillation at 130~140˚C is an efficient method to extract turmerones in high yield. On the other hand, the yield of Fr. 2 was 11.4% and the main component turned out to be l-zingiberene, which occupied 13.4% of the fraction. β-Sesquiphellandrene and ar-curcumene showed high content at 11.4 and 10.5%, respectively (Fig. 1 ). The other contents were low amounts of diterpenes and monoterpenes. From these results, Fr. 2 mainly consists of sesquiterpenes, which share a bisabolane-type skeleton with turmerones. Yields are indicated by the g of each fraction obtained from 100 g of crude essential oil.
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The lowest temperature fraction, Fr. 1 showed the lowest yield at only 1.6% collected from the crude essential oil extract. The constituents of Fr. 1 were mainly monoterpenes, namely αphellandrene, p-cymene and 1,8-cineole, and their concentrations were 31.0%, 21.0% and 12.9%, respectively.
These results demonstrated that the temperature of vacuum distillation affects the content of the compounds in that lower temperatures may extract various compounds while higher temperatures extract mainly turmerone, a member of the sesquiterpenes class.
The inhibitory activities of crude essential oil extract and Fr. 1~5 against β-secretase were assayed and the results are shown in Table  2 . Fr. 3, 4 and 5 showed relatively high potency at 69.2, 74.3 and 63.2% at 250 μg/mL, respectively. The potencies of these fractions should be attributed to turmerones. Interestingly, Fr. 2 showed a high potency of 57.1% at 250 μg/mL, although the turmerones content was relatively low. This result suggests that another active principle may be contained in Fr. 2, and this prompted us to investigate the active principles in Fr. 2. The fraction was subjected to silicic acid column chromatography to obtain 5 fractions (Fr. 2-1~2-5). Results of GC analyses of the fractions are shown in Table  3 . In Fr. 2-1, the main constituent was l-zingiberene at 34.4%, followed by β-sesquiphellandrene (21.6%), β-caryophyllene (14.8%), ar-curcumene (9.5%) and β-bisabolene (7.0%). Moreover, ar-curcumene was the single compound detected in Fr. 2-2 and 2-3. The high polar compounds eluted in Fr. 2-4 and 2-5 were a mixture of turmerone derivatives. Each value represents the mean ± S. D. of triplicates. Significantly different from the control at **: P<0.01.
The inhibitory activities of Fr. 2-1 to 2-5 against β-secretase are shown in Table 4 . Among the fractions obtained, Fr. 2-4 showed the most potent inhibitory activity of 87.2% at 250 μg/mL. Also, Fr. 2-5 showed a relatively high potency of 63.5% at 250 μg/mL. The potencies of these fractions may be attributed to turmerones. In addition, Fr. 2-1 showed relatively high inhibitory activity, 77.9%, at 250 μg/mL. This activity may be attributed to the compounds found by GC-MS [5] . As shown in Table 5 , l-zingiberene, βbisabolene, β-sesquiphellandrene and ar-curcumene showed moderate activities of 398, 552, 447 and 470 μM as IC 50 values. β-Caryophyllene was shown as a moderate inhibitor of β-secretase (IC 50 =4.2 mM) in a previous report [2] . From these results, we were able to reveal new β-secretase inhibitors.
Since turmerones showed more potent activities of 39~92 μM as an IC 50 value compared with the sesquiterpenes determined in this study, the existence of a ketone group at the C9 position may be dominant for inhibitory activity, increasing potency by approximately five to ten times.
Fr. 1 also showed moderate inhibitory activity of 33.4% at 250 μg/mL. This result prompted us to pursue the active principles. We then evaluated the inhibitory activities of the main components of Fr. 1, α-phellandrene, p-cymene and 1,8-cineole, along with the minor components, d-limonene and terpinolene, against β-secretase at 250 μg/mL using authentic samples. The results are shown in Table 6 . Among the monoterpenes tested, p-cymene showed the most potent activity at 39.1%. All compounds showed moderate activity, but it was not possible to elucidate the IC 50 values due to suppression of the activity at the higher concentration. Each value represents the mean ± S. D. of triplicates. Significantly different from the control at **: P<0.01.
Pharmacokinetic studies of turmerones were performed using a mouse model. Turmerones were administered orally and the brains were dissected after 30 min to evaluate the concentration of turmerones by LC-MS/MS. The results are shown in Figure 2 . α-Turmerone, β-turmerone and ar-turmerone were detected at 290, 398 and 65 ng/g in serum, 362, 640 and 118 ng/g in cerebrum, and 505, 926 and 150 ng/g in cerebellum, respectively. These results demonstrate that turmerones can pass through the blood-brain barrier in mice and reach the brain at a reasonable concentration in an intact form able to inhibit the enzyme. Along with the proliferation of neural stem cells, ar-turmerone may be an effective constituent in essential oil extract of turmeric for the prevention of AD [6] . Each value represents the mean ± S. D. of triplicates.
Significantly different from the control at **: P <0.01. Inhibitor: Lys-Thr-Glu-Glu-Ile-Ser-Glu-Val-Asn-Sta-Val-Ala-Glu-Phe. In this study, the efficiencies of steam distillation and vacuum distillation for extracting β-secretase inhibitors were disclosed. The method was suitable for obtaining low polar molecules such as monoterpenes and sesquiterpenes from turmeric. The activity and GC-MS guided investigation of active principles led us to determine four bisabolane-type sesquiterpenes, l-zingiberene, βsesquiphellandrene, ar-curcumene and β-bisabolene. The inhibitory activities were low (IC 50 : 398~552 μM) compared with α-, β-, and ar-turmerones (IC 50 : 39~92 μM). The increase of potency may be attributable to the existence of a ketone group at the C9 position since they share the same skeleton and functional groups. Interestingly, β-, α-and ar-turmerones penetrated the blood-brain barrier and were detected both in cerebrum and cerebellum. These findings suggest that turmerones, especially β-turmerone may be dominant for the prevention of AD since it reaches the brain directly and has a potency of IC 50 =62 μM [1] , which is relatively high among the active principles already identified. The transition of α-and β-turmerone to the brain by oral administration was clarified for the first time and potency for the prevention of AD demonstrated along with ar-turmerone. In a previous report, the inhibitory activities of some bisabolane-type sesquiterpenes against acetylcholinesterase were reported [7] . Moreover, ar-turmerone has an anti-inflammatory effect on glial cells, which leads to the protection of nerve cells [8] . Our results, combined with previously reported results, suggest that turmerones are a promising naturally occurring compound for the prevention of AD.
In addition, some monoterpenes contained in the essential oil extract were revealed to inhibit β-secretase. These results may also add new β-secretase inhibitors.
Moreover, we have already determined curcuminoids as moderate β-secretase inhibitors. Unfortunately, they are reported as metabolizing very quickly into sulfate or glutathione conjugates [9] . This suggests that turmerones are preferable for the prevention of AD and the usefulness of essential oil extract, which contains a small amount of curcuminoids, could be demonstrated. Study on the mode of action and the effects on neural cells of turmerones are now underway and will be discussed elsewhere. Preparation of crude essential oil extract: Turmeric (500 g) was pulverized and soaked in 5 v/w of water and subjected to steam distillation under atmospheric pressure. The distilled product (1,500 g) was obtained and centrifuged at 3,000 rpm for 3 min to obtain the crude essential oil extract (13 g, yield 2.6%).
Preparation of essential oil extract by vacuum distillation:
The crude essential oil extract (100 g) was subjected to vacuum distillation under 150 Pa at 110˚C to obtain Fr. 1, at 120˚C to obtain Fr. 2, at 130˚C to obtain Fr. 3 and at 140˚C to obtain Fr. 4. The residue was named Fr. 5.
Inhibitory assay for β-secretase:
The assay was performed according to the method reported by Murata et al. [2] . The β-secretase inhibitor was used as a reference compound. Preparative HPLC: Fr. 2-1, 2-2 and 2-3 were subjected to preparative HPLC, under the conditions shown below, to isolate the active principles [10, 11] . Column: L-column ODS (20 i.d. x 250 mm), Mobile phase: water/acetonitrile (5 : 95, v/v), Flow rate: 18.9 mL/min, Detection: UV 190 and 243 nm. Pharmacokinetic study: All animal experiments were approved by the Institutional Animal Care and Use Committee, and performed according to the Kindai University Animal Experimentation Regulations (Approval number; KAAG-25-002). Five-week-old male Slc: ddy mice (Shimizu Laboratory Supplies, Kyoto, Japan) were fed with a standard diet (Oriental Yeast, Tokyo, Japan) and provided with tap water ad libitum, in a humidity-controlled room, with a 12-h light / 12-h dark cycle. The room temperature was maintained at 25±1˚C. After habituation for 1 week, the mice were divided into 3 groups (vehicle, α-, β-and ar-turmerone groups). α-, β-and ar-turmerone were dissolved in a 2% carboxymethyl cellulose solution. Each sample was orally administered. After 30 min, blood and brain were collected. Serum was obtained by centrifugation at 3,000 rpm for 10 min. Brain samples were quickly frozen in liquid nitrogen and stored at -80°C until analysis by LC-MS.
GC and GC-MS analyses

LC-MS analysis of turmerones in serum and tissue sample:
Plasma extraction: Plasma sample (100 μL) and 500 μL of MeCN were combined and extracted for 3 min with vortex. The solution was then centrifuged (3,000 rpm for 3 min). The supernatant was obtained for LC-MS analysis.
Brain extraction: Brain sample (30 mg) was pulverized and extracted with 150 μL of MeCN. After 10 min of vortex and sonication, the suspension was centrifuged at 3,000 rpm for 3 min. The supernatant was used in LC-MS analysis. 
Turmerones analysis:
Statistical analysis:
All data were analyzed statistically by one-way analysis of variance (ANOVA) followed by a multiple comparison test (Bonferroni/Dunn algorithm). The analyses were performed using Statcel 3 (The Publisher OMS Ltd., Saitama, Japan) software. The data are shown in means of triplicates with error bars indicating standard deviations.
